US phase 3 ASTRA (NCT07368959) will enroll across ~12 sites, randomizing patients to a single intracameral administration of ...

Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery ...

Building on validated HIP technology, Sana Biotechnology is advancing SC451, a stem cell-derived therapy designed as a one-time treatment targeting normal blood glucose without exogenous insulin or ...

Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.

Superficial keratectomy with cryopreserved amniotic membrane may be safe and effective for treating epithelial basement membrane dystrophy.

We all have that one fun little quirk about our bodies that we like to show off as a party trick. Like pushing out your thumb ...

Ongoing; DT-818 (DM1) Dosing in Patients Expected in the First Half of 2026 Cash and Securities of $219.8 Million as of Year-End Supports Ongoing Clinical Execution CARLSBAD, Calif., March 09, 2026 ...

Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...

IL10 secretion accelerated corneal wound healing in mice, and IL10 receptor blockade abrogated benefit, supporting a ...